Retraction Note: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo

Retraction Note: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo

This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13048-019-0593-2.

書目詳細資料
Main Authors:	Zhi-Ying Qi, Fang Wang, Ying-Ying Yue, Xue-Wang Guo, Rui-Meng Guo, Hong-Lin Li, Yan-Ying Xu
格式:	Article
語言:	English
出版:	BMC 2023-08-01
叢編:	Journal of Ovarian Research
在線閱讀:	https://doi.org/10.1186/s13048-023-01267-2

相似書籍

RETRACTED ARTICLE: CYPA promotes the progression and metastasis of serous ovarian cancer (SOC) in vitro and in vivo
由: Zhi-Ying Qi, et al.
出版: (2019-11-01)

Retraction Note: Systematic analyses reveal long non-coding RNA (PTAF)-mediated promotion of EMT and invasion-metastasis in serous ovarian cancer
由: Haihai Liang, et al.
出版: (2023-04-01)

Gastric metastasis of ovarian serous cystadenocarcinoma
由: Yang S
出版: (2018-09-01)

Characterization of candidate factors associated with the metastasis and progression of high-grade serous ovarian cancer
由: Huiping Liu, et al.
出版: (2023-12-01)

SOCS7/HuR/FOXM1 signaling axis inhibited high-grade serous ovarian carcinoma progression
由: Yanhua Du, et al.
出版: (2022-05-01)

Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer
由: Yifan Cheng, et al.
出版: (2024-04-01)

Ovarian serous carcinoma with stomach metastasis: a rare case report and literature review
由: Jia-Li Hu, et al.
出版: (2024-04-01)

LPCAT3 regulates the proliferation and metastasis of serous ovarian cancer by modulating arachidonic acid
由: Fang Wen, et al.
出版: (2025-02-01)

Isolated Axillary Lymph Node Metastasis from Serous Ovarian Cancer
由: Hemant Goyal, et al.
出版: (2012-01-01)

A Rare Case of Ovarian Serous Borderline Tumor with Brain Metastasis
由: Sonia Veran-Taguibao, et al.
出版: (2019-01-01)

Low-Grade Ovarian Serous Adenocarcinoma with Lymph Node Metastasis in Neck
由: Shih-Lung Chen, et al.
出版: (2021-09-01)

Solitary splenic metastasis of serous ovarian cancer: A rare manifestation
由: Fei Liu, et al.
出版: (2023-02-01)

Cardiophrenic lymph node metastasis in low-grade serous ovarian adenocarcinoma
由: Tasha Serna-Gallegos, et al.
出版: (2017-02-01)

Testicular serous carcinoma of ovarian epithelial type
由: Chang-Hong Yeh, et al.
出版: (2017-06-01)

Retraction Note: Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis
由: Li Huang, et al.
出版: (2023-01-01)

Metastasis of serous ovarian carcinoma to the breast: a case report and review of the literature
由: Sofia Dueño, et al.
出版: (2024-03-01)

Serous borderline tumor with distant mediastinal metastasis? An Exceptional presentation of ovarian tumor
由: Julia M. Sołek, et al.
出版: (2022-01-01)

Age is associated with prognosis in serous ovarian carcinoma
由: Fei Deng, et al.
出版: (2017-06-01)

RUNX1 knockdown induced apoptosis and impaired EMT in high-grade serous ovarian cancer cells
由: Yuanzhi Chen, et al.
出版: (2023-12-01)

Digital pathology-based study of cell- and tissue-level morphologic features in serous borderline ovarian tumor and high-grade serous ovarian cancer
由: Jun Jiang, et al.
出版: (2021-01-01)

Cardiophrenic lymph node metastasis as the sole presentation of high grade serous ovarian carcinoma
由: Thomas Julius Henning, et al.
出版: (2024-09-01)

Mediastinal metastasis from ovarian serous carcinoma 29 years after initial treatment
由: Eri Inoue, et al.
出版: (2020-01-01)

CypA, a gene downstream of HIF-1α, promotes the development of PDAC.
由: Huan Zhang, et al.
出版: (2014-01-01)

Immune cell landscapes are associated with high-grade serous ovarian cancer survival
由: Guoan Zhang, et al.
出版: (2024-07-01)

Retraction Note: Fibulin-3 knockdown inhibits cervical cancer cell growth and metastasis in vitro and in vivo
由: Juan Li, et al.
出版: (2023-07-01)

Radiomics nomogram for preoperative differentiation of early-stage serous borderline ovarian tumors and serous malignant ovarian tumors
由: Xinping Yu, et al.
出版: (2024-01-01)

Effect and mechanism of CyPA in radiosensitization of lung adenocarcinoma using CRISPR/Cas9 technology
由: Jinkun Ma, et al.
出版: (2020-03-01)

Retraction Note: Correlation of CD44v6 expression with ovarian cancer progression and recurrence
由: Jun Shi, et al.
出版: (2020-03-01)

Anticancer effects of Erzhimaoling decoction in high-grade serous ovarian cancer in vitro and in vivo
由: Li Yang, et al.
出版: (2024-08-01)

The Epithelial-Mesenchymal Transition, E-cadherin and Tumor Progression in Ovarian Serous Tumors
由: Bozhkova Desislava M., et al.
出版: (2019-06-01)

Correction to: Systematic analyses reveal long non-coding RNA (PTAF)-mediated promotion of EMT and invasion-metastasis in serous ovarian cancer
由: Haihai Liang, et al.
出版: (2020-12-01)

A PTAL-miR-101-FN1 Axis Promotes EMT and Invasion-Metastasis in Serous Ovarian Cancer
由: Haihai Liang, et al.
出版: (2020-03-01)

TRIM5α restricts poxviruses and is antagonized by CypA and viral protein C6
由: Zhao, Y, et al.
出版: (2023)

CYPA, a novel and potential genetic adjuvant enhanced HIV-1 DNA vaccine immunoreactivity
由: Hou J, et al.
出版: (2012-09-01)

Development and validation of an ultrasound‑based radiomics nomogram to predict lymph node status in patients with high-grade serous ovarian cancer: a retrospective analysis
由: Yue Qi, et al.
出版: (2024-02-01)

A single-cell landscape of pre- and post-menopausal high-grade serous ovarian cancer ascites
由: Wenying Chen, et al.
出版: (2023-10-01)

HDAC9 Contributes to Serous Ovarian Cancer Progression through Regulating Epithelial–Mesenchymal Transition
由: Long Xu, et al.
出版: (2022-02-01)

Differential microma expression in primary peritoneal serous carcinoma versus ovarian serous
由: O'Leary, J, et al.
出版: (2008)

Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
由: Huan Wu, et al.
出版: (2019-12-01)

Dynamics of the Intratumoral Immune Response during Progression of High-Grade Serous Ovarian Cancer
由: Mandy Stanske, et al.
出版: (2018-03-01)